Martin Tichý

Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry

2022 | Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine

Publication